SPG/IND-induced septic shock in a LPS-low responder strain, C3H/HeJ mice

Microbial Pathogenesis

Volumn 44, Issue 5, 2008, Pages 402-409

  Saito, Maki ^a   Nameda, Sachiko ^a   Miura, Noriko N ^a   Adachi, Yoshiyuki ^a   Ohno, Naohito ^a  

^a TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

Author keywords

Glucan; C3H HeJ; Indomethacin; LPS; PAMPs; Sepsis

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BETA GLUCAN; INDOMETACIN; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; NONSTEROID ANTIINFLAMMATORY AGENT; SCHIZOPHYLLAN; TUMOR NECROSIS FACTOR ALPHA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; C3H MOUSE; COMPARATIVE STUDY; CONTROLLED STUDY; DEATH; EXPERIMENTAL MODEL; GASTROINTESTINAL TRACT; LETHALITY; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; RECTUM TEMPERATURE; SEPTIC SHOCK; UPREGULATION; VIRULENCE; WEIGHT REDUCTION;

ALANINE TRANSAMINASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; BODY TEMPERATURE; BODY WEIGHT; GASTROINTESTINAL TRACT; INDOMETHACIN; INTERLEUKIN-6; MALE; MICE; MICE, INBRED C3H; SHOCK, SEPTIC; SIZOFIRAN; SURVIVAL ANALYSIS; TUMOR NECROSIS FACTOR-ALPHA;

BACTERIA (MICROORGANISMS); MUS;

EID: 42049094444     PISSN: 08824010     EISSN: 10961208     Source Type: Journal    
DOI: 10.1016/j.micpath.2007.11.003     Document Type: Article

References (40)

1. Bone R.C., Balk R.A., Cerra F.B., Dellinqer R.P., Fein A.M., Knaus W.A., et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM consensus conference committee. American college of chest physicians/society of critical care medicine. Chest 101 (1992) 1644-1655
2. Johnson D., and Mayers I. Multiple organ dysfunction syndrome: a narrative review. Can J Anaesth 48 (2001) 502-509
3. Cohen J. The immunopathogenesis of sepsis. Nature 420 (2002) 885-891
4. Lehmann V., Freudberg M.A., and Galanos C. Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and d-galactosamine-treated mice. J Exp Med 165 (1987) 657-663
5. Takada K., Ohno N., and Yadomae T. Binding of lysozyme to lipopolysaccharide suppresses tumor necrosis factor production in vivo. Infect Immun 62 (1994) 1171-1175
6. Ogata M., Matsui T., Kita T., and Shigematsu A. Carrageenan primes leukocytes to enhance lipopolysaccharide-induced tumor necrosis factor alpha production. Infect Immun 67 (1999) 3284-3289
7. Finlay B.B., and McFadden G. Anti-immunology: evasion of the host immune system by bacterial and viral pathogens. Cell 124 (2006) 767-782
8. Takeda K., and Akira S. Toll-like receptors in innate immunity. Int Immunol 17 (2005) 1-14
9. Takeda K. Evolution and integration of innate immune recognition systems: the Toll-like receptors. J Endotoxin Res 11 (2005) 51-55
10. Takeda K., and Akira S. Microbial recognition by Toll-like receptors. J Dermatol Sci 34 (2004) 73-82
11. Yoshioka S., Ohno N., Miura T., Adachi Y., and Yadomae T. Immunotoxicity of soluble beta-glucans induced by indomethacin treatment. FEMS Immunol Med Microbiol 21 (1998) 171-179
12. Takahashi H., Ohno N., Adachi Y., and Yadomae T. Association of immunological disorders in lethal side effect of NSAIDs on beta-glucan-administered mice. FEMS Immunol Med Microbiol 31 (2001) 1-14
13. Moriya K., Miura N.N., Adachi Y., and Ohno N. Systemic inflammatory response associated with augmentation and activation of leukocytes in Candida/indomethacin administered mice. Biol Pharm Bull 25 (2002) 816-822
14. Moriya K., Ohno N., Miura N.N., Adachi Y., and Yadomae T. Septic shock induced by microbial products and indomethacin. Drug Dev Res 55 (2002) 139-148
15. Nameda S., Saito M., Miura N.N., Adachi Y., and Ohno N. Effect of nitric oxide on beta-glucan/indomethacin-induced septic shock. Biol Pharm Bull 28 (2005) 1254-1258
16. Suffredini A.F., Fromm R.E., Parker M.M., Brenner M., Kovacs J.A., Wesley R.A., et al. The cardiovascular response of normal humans to the administration of endotoxin. N Engl J Med 321 (1989) 280-287
17. Danner R.L., Elim R.J., Hosseini J.M., Wesley R.A., Reilly J.M., and Parillo J.E. Endotoxemia in human septic shock. Chest 99 (1991) 169-175
18. Taveira da Silva A.M., Kaulbach H.C., Chuidian F.S., Lambert D.R., Suffredini A.F., and Danner R.L. Brief report: shock and multiple-organ dysfunction after self-administration of Salmonella endotoxin. N Engl J Med 328 (1993) 1457-1460
19. Henry D., Dobson A., and Turner C. Variability in the risk of major gastrointestinal complications from nonaspirin nonsteroidal anti-inflammatory drugs. Gastroenterology 106 (1993) 1078-1088
20. Mohamed A.H., Salena B.J., and Hunt R.H. NSAID-induced gastroduodenal ulcers: exploring the silent dilemma. J Gastroenterol 29 (1994) 34-38
21. Koch M., Dezi A., Ferrario F., and Capurso I. Prevention of nonsteroidal anti-inflammatory drug-induced gastrointestinal mucosal injury. A meta-analysis of randomized controlled clinical trials. Arch Intern Med 156 (1996) 2321-2332
22. Fosslien E. Adverse effects of nonsteroidal anti-inflammatory drugs on the gastrointestinal system. Ann Clin Lab Sci 28 (1998) 67-81
23. Griffin M.R. Epidemiology of nonsteroidal anti-inflammatory drug-associated gastrointestinal injury. Am J Med 104 (1998) 23S-29S
24. Moore R.A., Tramer M.R., Carroll D., Wiffen P.J., and McQuary H.J. Quantitative systematic review of topically applied non-steroidal anti-inflammatory drugs. BMJ 316 (1998) 333-338
25. Singh G. Recent considerations in nonsteroidal anti-inflammatory drug gastropathy. Am J Med 105 (1998) 31S-38S
26. Martin G.S., Mannino D.M., Eaton S., and Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348 (2003) 1546-1554
27. Shibata K., and Funada H. The epidemiology of SIRS.sepsis in Japan. Nippon Rinsho 62 (2004) 2184-2188
28. Nakamura T., and Takahashi H. Epidemiological study of Candida infections in blood: susceptibilities of Candida spp. to antifungal agents, and clinical features associated with the candidemia. J Infect Chemother 12 (2006) 132-138
29. Faulkner L., Cooper A., Fantino C., Altmann D.M., and Sriskandan S. The mechanism of superantigen-mediated toxic shock: not a simple Th1 cytokine storm. J Immunol 175 (2005) 6870-6877
30. Heine H., Kirschning C.J., Line E., Monks B.G., Rothe M., and Golenbock D.T. Cutting edge: cells that carry a null allele for toll-like receptor 2 are capable of responding to endotoxin. J Immunol 162 (1999) 6971-6975
31. Schwander R., Dziarski R., Wesche H., Rothe M., and Kirschning C.J. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2. J Biol Chem 274 (1999) 17406-17409
32. Takeuchi O., Hoshino K., Kawai T., Sanjo H., Takada H., Ogawa T., et al. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 11 (1999) 443-451
33. Yoshimura A., Lien E., Ingalls R.R., Tuomanen E., Dziarski R., and Golenbock D. Cutting edge: recognition of gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J Immunol 163 (1999) 1-5
34. Takeuchi O., Hoshino K., and Akira S. Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. J Immunol 165 (2000) 5392-5396
35. Takeda K., Kaisho T., and Akira S. Toll-like receptors. Annu Rev immunol 21 (2003) 335-376
36. Okayasu I., Hatakeyama S., Yamada M., Ohkusa T., Inagaki Y., and Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 98 (1990) 694-702
37. Elson C.O., Sartor R.B., Tennyson G.S., and Riddell R.H. Experimental models of inflammatory bowel disease. Gastroenterology 109 (1995) 1344-1367
38. Gaudio E., Taddei G., Vetuschi A., Sferra R., Frieri G., Ricciardi G., et al. Dextran sulfate sodium (DSS) colitis in rats: clinical, structural, and ultrastructural aspects. Dig Dis Sci 44 (1999) 1458-1475
39. Nakano S., Ohara S., Kubota T., Saigenji K., and Hotta K.J. Compensatory response of colon tissue to dextran sulfate sodium-induced colitis. Gastroenterol 34 (1999) 207-214
40. Diaz-Grandos N., Howe K., Lu J., and McKay D.M. Dextran sulfate sodium-induced colonic histopathology, but not altered epithelial ion transport, is reduced by inhibition of phosphodiesterase activity. Am J Pathol 156 (2000) 2169-2177